Anagenex

Recent Finacing

Series A

Recent Raise

$30M

Anagenex operates a closed-loop directed-evolution drug-discovery platform combining DNA-encoded libraries, affinity-selected mass spectrometry, automated miniaturized biochemical screening, and proprietary ML to iteratively design small molecules.